Mutations and transient conformational movements of the receptor binding domain (RBD)
that make neutralizing epitopes momentarily unavailable present immune escape routes for …

Advanced mRNA vaccines play vital roles against SARS-CoV-2. However, most current
mRNA delivery platforms need to be stored at −20 C or −70 C due to their poor stability, which …

Background Recombinant protein subunit vaccination is considered to be a safe, fast and
reliable technique when combating emerging and re-emerging diseases such as coronavirus …

Recombinant human interferon α2b (rhIFNα2b) is widely used as an antiviral therapy agent
for the treatment of hepatitis B and hepatitis C. The current identification test for rhIFNα2b is …

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has led to significant public health, economic and …

To investigate whether healthy animals are potential carriers of rabies virus in China, 153
domestic dogs were collected from a rabies enzootic area, Anlong county in Guizhou Province, …

Introduction ReCOV is a recombinant protein vaccine that aims to induce cross-neutralization
against SARS-CoV-2 variants. The phase I and phase II studies were conducted in New …

Polymeric immunoglobulin receptors (pIgR) are key participants in the formation and
secretion of secretory IgA (S-IgA), which is critical for the prevention of microbial infection and …

The long-acting growth hormone (LAGH) is a promising alternative biopharmaceutical to
treat growth hormone (GH) deficiency in children, and it was developed using a variety of …

Background Recombinant protein vaccines are vital for broad protection against SARS-CoV-2
variants. This study assessed ReCOV as a booster in two Phase 2 trials. Research design …